NCT06965114 2026-03-18Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell LeukemiaNational Cancer Institute (NCI)Phase 1/2 Recruiting84 enrolled
NCT00412594 2025-12-22Cladribine and Rituximab in Treating Patients With Hairy Cell LeukemiaM.D. Anderson Cancer CenterPhase 2 Recruiting150 enrolled